Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Giannarelli

Showing results (1-10 of 570) with videos related to

Pageof 57
Sort By:
Journal of Prenatal Medicine|November 1, 2013
Effect of vaginally administered DHA fatty acids on pregnancy outcome in high risk pregnancies for preterm delivery: a double blinded randomised controlled trialClaudio Giorlandino, Diana Giannarelli
Leukemia|June 23, 2020
Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysisStefano Molica, Diana Giannarelli
Leukemia|November 30, 2022
Retraction Note: Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysisStefano Molica, Diana Giannarelli
Annali Italiani Di Chirurgia|May 19, 2015
A comparison of two questionnaires on Informed Consent for extended criteria liver donorsPaolo Bruzzone, Diana Giannarelli
Leukemia & Lymphoma|February 27, 2023
Prognostic models predicting overall survival of chronic lymphocytic leukemia (CLL) patients treated with ibrutinib-based therapies: a systematic review and meta-analysisStefano Molica, Diana Giannarelli
European Journal of Haematology|November 15, 2020
Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysisStefano Molica, Tycho Baumann, Diana Giannarelli
Clinical Lymphoma, Myeloma & Leukemia|November 17, 2020
Comparison Between Venetoclax-based and Bruton Tyrosine Kinase Inhibitor-based Therapy as Upfront Treatment of Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Network Meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
European Journal of Haematology|December 2, 2021
mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
Clinical Lymphoma, Myeloma & Leukemia|April 28, 2019
Minimal Residual Disease and Survival Outcomes in Patients With Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
Leukemia & Lymphoma|March 4, 2026
Indirect comparison of continuous and time‑limited BTKi-venetoclax in <i>TP53</i>‑wild‑type CLL: does <i>IGHV</i> still matter?Stefano Molica, Diana Giannarelli, David Allsup
Pageof 57

Showing results (1-10 of 570) with videos related to

Sort By:
Pageof 57
Journal of Prenatal Medicine|November 1, 2013
Effect of vaginally administered DHA fatty acids on pregnancy outcome in high risk pregnancies for preterm delivery: a double blinded randomised controlled trialClaudio Giorlandino, Diana Giannarelli
Leukemia|June 23, 2020
Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysisStefano Molica, Diana Giannarelli
Leukemia|November 30, 2022
Retraction Note: Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysisStefano Molica, Diana Giannarelli
Annali Italiani Di Chirurgia|May 19, 2015
A comparison of two questionnaires on Informed Consent for extended criteria liver donorsPaolo Bruzzone, Diana Giannarelli
Leukemia & Lymphoma|February 27, 2023
Prognostic models predicting overall survival of chronic lymphocytic leukemia (CLL) patients treated with ibrutinib-based therapies: a systematic review and meta-analysisStefano Molica, Diana Giannarelli
European Journal of Haematology|November 15, 2020
Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysisStefano Molica, Tycho Baumann, Diana Giannarelli
Clinical Lymphoma, Myeloma & Leukemia|November 17, 2020
Comparison Between Venetoclax-based and Bruton Tyrosine Kinase Inhibitor-based Therapy as Upfront Treatment of Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Network Meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
European Journal of Haematology|December 2, 2021
mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
Clinical Lymphoma, Myeloma & Leukemia|April 28, 2019
Minimal Residual Disease and Survival Outcomes in Patients With Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
Leukemia & Lymphoma|March 4, 2026
Indirect comparison of continuous and time‑limited BTKi-venetoclax in <i>TP53</i>‑wild‑type CLL: does <i>IGHV</i> still matter?Stefano Molica, Diana Giannarelli, David Allsup
Pageof 57